What are you looking for?

Common searches: Departments, Hospitalisation, Professionals, Outpatient clinics, Health advice, Accreditations, Diseases, Diagnostic tests, Treatments, The birth of a child, Emergency, Visiting patients,

Activities

Diagnóstico Molecular para residentes de alergia

 Más información: https://aula.vallhebron.com/index.php?go=info_cursos&curso=644 Aula Vall d'H

News

Renal cell metabolism in diabetic men predisposes to renal disease

 An international study involving the Hospital del Mar Research Institute and VHIR shows that there are substantial differences between men and women in the energy metabolism of of renal tubular cells.

Activities

Cáncer en el adolescente y adulto joven (AYA): Del diagnóstico precoz al seguimiento a largo plazo

 Más información: https://aula.vallhebron.com/?go=info_cursos&curso=658&idioma=es Aula Vall d'Hebron Secretaría Técnica actividades formativas externas Mail: inscripcions@aulavallhebron.cat tel: 693.785.436

News

Vall d'Hebron participates in an international clinical trial that has led to approval of the first drug for advanced fatty liver disease

 Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

Activities

III Curso formación en Simulación clínica en Alergia

 Más información: https://aula.vallhebron.com/?go=info_cursos&curso=641&idioma=es

ECMO Program

 An opportunity for some patients with heart failure or severe respiratory disease for whom conventional therapeutic measures are no longer effective. A multidisciplinary team of experts and state-of-the-art technologies provide extracorporeal life support, with a better clinical context and more

Professionals

Anna Creus Costa

 I am a medical resident in Pediatrics. In 2023, I joined the research group Infection and Immunity in pediatric patients.

News

A new therapeutic strategy improves the control of motor symptoms in patients with Parkinson's disease

 Vall d'Hebron has participated in a phase III clinical trial which confirmed the efficacy and safety of subcutaneous infusion of levodopa therapy.

Activities

Actualizaciones y controversias en la monitorización de la PIC y de la presión de perfusión cerebral en el paciente neurocrítico

 Más información: https://aula.vallhebron.com/aula/?go=info_cursos&curso=660 Para cualquier otra información

Professionals

Mar Hernández Guillamon

 Senior Researcher, Neurovascular Research Lab, VHIR.

Subscribe to our newsletters and be a part of Campus Life

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”.
Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health).
Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information.
Legal basis: Consent of the data subject.
Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen.
Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time.
Source: The data subject.
Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.